Autoimmune hepatitis in a HIV-HCV co-infected patient: diagnostic ant therapeutic difficulties;Hépatite auto-immune chez une patiente co-infectée VIH-VHC : difficultés diagnostiques et thérapeutiques

Revue de Medecine Interne

Volumn 27, Issue 5, 2006, Pages 414-419

  Cazanave, C ^a   Rakotondravelo, S ^a   Morlat, P ^a   Blanco, P ^b   Bonnet, F ^a   Beylot, J ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

Autoimmune hepatitis; HCV; HIV; Treatment

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; EFAVIRENZ; INTERFERON; LAMIVUDINE; PEGINTERFERON; PREDNISONE; RIBAVIRIN; STAVUDINE;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LIVER BIOPSY; OPPORTUNISTIC INFECTION; RELAPSE; REMISSION;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HIV INFECTIONS; HUMANS; LIVER FUNCTION TESTS; RIBAVIRIN;

EID: 33646547657     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.01.016     Document Type: Article

References (24)

1. Kessler W.R., Cummings O.W., Eckert G., Chalasani N., Lumeng L., and Kwo P.Y. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin. Gastroenterol. Hepatol. 2 (2004) 625-631
2. Carpenter H.A., and Czaja A.J. The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants. Clin. Liver Dis. 6 (2002) 685-770
3. Duclos-Vallée J.C., Johanet C., Sebagh M., Samuel D., and Yamamoto A.M. Hépatites auto-immunes. Aspects physiopathologiques, cliniques, histologiques et thérapeutiques. Ann. Med. Interne (Paris) 152 (2001) 371-382
4. Vergani D., and Mieli-Vergani G. Autoimmune hepatitis. Autoimmun. Rev. 2 (2003) 241-247
5. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 31 (1999) 929-938
6. Czaja A.J. Treatment of autoimmune hepatitis. Semin. Liver Dis. 22 (2002) 365-378
7. German V., Vassiloyanakopoulos A., Sampaziotis D., and Giannakos G. Autoimmune hepatitis in an HIV infected patient that responded to antiretroviral therapy. Scand. J. Infect. Dis. 37 (2005) 148-151
8. Zandman-Goddard G., and Shoenfeld Y. HIV and autoimmunity. Autoimmun. Rev. 1 (2002) 329-337
9. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematous. Arthritis Rheum. 40 (1997) 1725
10. Arnett F.C., and Reichlin M. Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P. Am. J. Med. 99 (1995) 465-472
11. Miyakawa H., Kawashima Y., Kitazawa E., Kawaguchi N., Kato T., Kikuchi K., et al. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. J. Autoimmun. 21 (2003) 77-82
12. Tojo J., Ohira H., Abe K., Yokokawa J., Takiguchi J., Rai T., et al. Autoimmune hepatitis accompanied by systemic lupus erythematous. Intern. Med. 43 (2004) 258-262
13. Cacoub P., Renou C., Rosenthal E., Cohen P., Loury I., Loustaud-Ratti V., et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC (Groupe d'étude et de recherche en médecine interne et maladies infectieuses sur le virus de l'hépatite C). Medicine (Baltimore) 79 (2000) 47-56
14. Vitozzi S., Lapierre P., Djilali-Saiah I., Marceau G., Beland K., and Alvarez F. Antisoluble liver antigen (SLA) antibodies in chronic HCV infection. Autoimmunity 37 (2004) 217-222
15. Ben-Ari Z., and Czaja A.J. Autoimmune hepatitis and its variant syndromes. Gut 49 (2001) 589-594
16. Strassburg C.P., Vogel A., and Manns M.P. Autoimmunity and hepatitis. Autoimmun. Rev. 2 (2003) 322-331
17. Ballot E., Homberg J.C., and Johanet C. Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis. J. Hepatol. 33 (2000) 208-215
18. Czaja A.J., Shums Z., and Norman G.L. Non-standard antibodies as prognostic markers in autoimmune hepatitis. Autoimmunity 37 (2004) 195-201
19. Lunel F., and Cacoub P. Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection. J. Hepatol. 31 Suppl 1 (1999) 210-216
20. Schiano T.D., Te H.S., Thomas R.M., Hussain H., Bond K., and Black M. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. Am. J. Gastroenterol. 96 (2001) 2984-2991
21. Petersen-Benz C., Kasper H.U., Dries V., and Goeser T. Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis C-autoimmune hepatitis overlap syndrome. Clin. Gastroenterol. Hepatol. 2 (2004) 440-443
22. Rocca P., Codes L., Chevallier M., Trepo C., and Zoulim F. Auto-immunité induite par l'interféron alpha lors du traitement d'une hépatite C chronique. Gastroenterol. Clin. Biol. 28 (2004) 1173-1176
23. Czaja A.J., and Carpenter H.A. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology 39 (2004) 1631-1638
24. Krawitt E.L. Autoimmune hepatitis. N. Engl. J. Med. 334 (1996) 897-903